Citation: P. Paquet et al., Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins, BURNS, 27(6), 2001, pp. 652-655
Authors:
Reinhart, K
Menges, T
Gardlund, B
Zwaveling, JH
Smithes, M
Vincent, JL
Tellado, JM
Salgado-Remigio, A
Zimlichman, R
Withington, S
Tschaikowsky, K
Brase, R
Damas, P
Kupper, H
Kempeni, J
Eiselstein, J
Kaul, M
Citation: K. Reinhart et al., Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study, CRIT CARE M, 29(4), 2001, pp. 765-769
Authors:
Mathy-Hartert, M
Damas, P
Nys, M
Deby-Dupont, G
Canivet, JL
Ledoux, D
Lamy, M
Citation: M. Mathy-hartert et al., Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia, EUR RESP J, 16(2), 2000, pp. 296-301
Authors:
Nys, M
Ledoux, D
Canivet, JL
De Mol, P
Lamy, M
Damas, P
Citation: M. Nys et al., Correlation between endotoxin level and bacterial count in bronchoalveolarlavage fluid of ventilated patients, CRIT CARE M, 28(8), 2000, pp. 2825-2830
Authors:
Laureys, S
Faymonville, ME
Degueldre, C
Del Fiore, G
Damas, P
Lambermont, B
Janssens, N
Aerts, J
Franck, G
Luxen, A
Moonen, G
Lamy, M
Maquet, P
Citation: S. Laureys et al., Auditory processing in the vegetative state, BRAIN, 123, 2000, pp. 1589-1601
Authors:
Nys, M
Damas, J
Damas, P
Laub, R
Cloes, JM
Lamy, M
Citation: M. Nys et al., Study of the protective effects of hyperimmune immunoglobulins G and M against endotoxin in mice and rats, MED MICROBI, 188(2), 1999, pp. 55-64
Citation: M. Nys et al., Influence of human anti-lipopolysaccharide immunoglobulins on tissue distribution and clearance of lipopolysaccharide in rats, MED MICROBI, 188(2), 1999, pp. 65-71
Authors:
Colardijn, F
Damas, P
De Mol, P
Glupczynski, Y
Gordus, B
Ronveaux, O
Struelens, M
Thys, JP
Verhaegen, J
Vogelaers, D
Wilmotte, L
Bossens, M
Byl, B
Carpentier, M
Claeys, G
Crokaert, F
Daux, J
Dediste, A
De Jongh, D
Delporte, JP
Desmet, F
d'Hollander, A
Ezzedine, H
Fameree, D
Garrino, M
Goossens, H
Govaerts, D
Hecq, JD
Ieven, G
Jacobs, F
Jordens, P
Larbuisson, W
Laterre, PF
Lauwers, S
Lefebure, B
Lievin, V
Meert, P
Melin, P
Mertens, A
Moulin, D
Peetermans, W
Peleman, R
Potvliege, C
Reynaert, M
Rost, F
Simon, A
Sion, JP
Stuyck, J
Valcke, Y
Van Beek, F
Vandercam, B
Van Laethem, Y
Van Landuyt, H
Van Vooren, JP
Van Wyngaarden, E
Verbist, L
Verschraegen, G
Vincent, JL
Wauters, G
Willems, L
Citation: F. Colardijn et al., GDEPIH-GOSPIZ Belgian consensus strategies to control antibiotic-resistantbacteria in hospitals, ACT CLIN B, 54(1), 1999, pp. 15-16
Authors:
Dhainaut, JFA
Tenaillon, A
Hemmer, M
Damas, P
Le Tulzo, Y
Radermacher, P
Schaller, MD
Sollet, JP
Wolff, M
Holzapfel, L
Zeni, F
Vedrinne, JM
de Vathaire, F
Gourlay, ML
Guinot, P
Mira, JP
Holzapfel, L
Demingeon, G
Piralla, B
Zeni, F
Bertrand, JC
Motin, J
Vedrinne, JM
Dreyfuss, D
Coste, F
Mier, L
Faller, JP
Ruyer, O
Feissel, M
Engquist, A
Strom, J
Bonde, J
Desmonts, JM
Montravers, P
Lagoueyte, JF
Tenaillon, A
Lawkoune, JM
Boiteau, R
Cardinaud, JP
Benissan, G
Chastre, J
Gibert, C
Daoudal, P
Delacourt, M
Fouet, P
Hilpert, F
Smithies, M
Bihari, D
Perrotin, D
Dequin, PF
Tempelhof, G
Carton, MJ
Payen, D
Mateo, J
Carlet, J
Lescale, O
Bleichner, G
Sollet, JP
Fagon, JY
Novara, A
Dhainaut, JF
Marin, N
Galiacy, JL
Morteau, B
Wolff, M
Vachon, F
Durocher, A
Saulnier, F
Herman, B
Wysocki, M
Duswald, M
Radermacher, P
Georgieff, M
Colardyn, F
Robert, D
Park, G
Mattei, M
Charbonneau, P
Chopin, C
Breulmann, M
Holzheimer, M
Damas, F
Ozier, Y
Fraisse, F
Gastrinne, H
Blanc, PL
Domart, Y
Aube, H
Descamps, JM
Nitenberg, G
Tempe, JD
Bonnet, F
Jaeger, A
Villers, D
Barale, F
Falke, K
Ulbricht, M
Samii, K
Pepperman, M
Tonnesen, E
Gattinoni, L
Braschi, A
Arich, C
Lienhart, A
Offenstadt, G
Eurin, B
Schlemmer, B
Goenen, M
Bahr, R
Brienza, A
Antonelli, M
Damas, P
Edwards, D
Citation: Jfa. Dhainaut et al., Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial, CRIT CARE M, 26(12), 1998, pp. 1963-1971